Wang-Johanning Feng

Feng Wang-Johanning received the M.D. and Ph.D. degrees from the University of Tianjin Medical School in Tianjin, China, and the M.S. degree from Ohio University, Athens, OH, USA. She received her postdoctoral training in the Gene Therapy Center at The University of Alabama at Birmingham, Birmingham, AL, USA. She has worked at two NCI-designated Cancer Centers, the Comprehensive Cancer Center at The University of Alabama at Birmingham and The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. She has developed assays for human papillomavirus (HPV) detection. Currently, she is the Director of Viral Oncology in the Center for Cancer and Metabolism at SRI International, Menlo Park, CA, USA. Her laboratory was the first to show that human endogenous retroviruses (HERVs) are selectively expressed in many human cancers including breast, ovarian, prostate, and melanoma. Her research focus is basic and translational studies of retroviruses as a potential target for the detection and diagnosis of cancer, and for developing cancer vaccines and therapeutic antibodies. Her research has been funded by the Department of Defense, the Komen Foundation, and the Avon Foundation. Her work has appeared in the Journal of the National Cancer Institute, Cancer Research, and Clinical Cancer Research.